Refresh

Aurobindo Pharma Ltd. - Research Center

524804 AUROPHARMA Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

10,645.64 12,792.28 11,287.14 15,823.68 13,266.48
Expenses

Material consumed

5,917.42 7,009.99 5,981.37 7,425.56 6,692.42

Manufacturing expenses

191.58 613.92 477.99 512.34 520.30

Personnel expenses

980.56 1,641.88 1,600.04 1,735.42 1,561.47

Selling expenses

- - - - -

Adminstrative expenses

1,332.04 1,795.57 1,754.34 2,030.53 1,806.54

Expenses capitalised

- - - - -

Cost of sales

8,421.60 11,061.36 9,813.74 11,703.85 10,580.73

Operating profit

2,224.04 1,730.92 1,473.40 4,119.83 2,685.75

Other recurring income

616.06 433.76 670.99 589.86 403.37

Adjusted PBDIT

2,840.10 2,164.68 2,144.39 4,709.69 3,089.12

Financial expenses

182.60 114.98 16.94 28.68 240.94

Depreciation

254.58 435.35 415.26 488.00 470.48

Other write offs

- - - - -

Adjusted PBT

2,402.92 1,614.35 1,712.19 4,193.01 2,377.70

Tax charges

502.82 383.94 182.77 1,080.10 504.96

Adjusted PAT

1,900.10 1,230.41 1,529.42 3,112.91 1,872.74

Non recurring items

52.35 5.87 -73.02 -6.42 -

Other non cash adjustments

- - - - -

Reported net profit

1,952.45 1,236.28 1,456.40 3,106.49 1,872.74

Earnigs before appropriation

18,612.53 17,100.42 16,127.81 14,905.79 12,032.87

Equity dividend

263.66 439.45 263.67 234.38 166.12

Preference dividend

- - - - -

Dividend tax

- - - - 9.66

Retained earnings

18,348.87 16,660.97 15,864.14 14,671.41 11,857.09
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com